Skip To Main Content
Anna-Carson R. Uhelski on Muck Rack

Anna-Carson R. Uhelski

As seen in: Wiley Online Library
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Anna-Carson R.

Contact Anna-Carson R., search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

End‐Of‐Life Outcomes and Healthcare Utilization for Patients With Hepatocellular Carcinoma Who Received Immune Checkpoint Inhibition

|
By Henry Domenico, Margaret C. Wheless, Anna-Carson R. Uhelski, Sarah K. Cimino
| Wiley Online Library Verified
1 Introduction With the development and incorporation of immune checkpoint inhibitors (ICI) into the treatment algorithm of hepatocellular carcinoma (HCC), the treatment paradigm has shifted drastically in the last several years, particularly for patients with Child Pugh A (CPA) cirrhosis.
Open in Who Shared Issue with article?
See all 1 articles